Lanthio Pharma
Groningen
About Lanthio Pharma
Lanthio Pharma is a privately held drug discovery company that applies its proprietary lanthionine-peptide drug discovery technology LanthioPepTM for the generation of novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity. Lanthio Pharma has generated stable, peptidase-resistant lanthionine peptides with highly specific agonistic activity for a number of GPCR targets, which is a focus area of the company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.1M
- Funding stage: M&A
- Last round: Debt Financing (May 2014)
- Website: lanthiopharma.com
- Phone: 31 50 305 0240
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lanthio-pharma-2786578 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.